Affordable Access

Publisher Website

A randomised phase II study of pemetrexed versus pemetrexed+erlotinib as second-line treatment for locally advanced or metastatic non-squamous non-small cell lung cancer

Authors
  • Dittrich, Christian
  • Papai-Szekely, Zsolt
  • Vinolas, Nuria
  • Sederholm, Christer
  • Hartmann, Joerg T.
  • Behringer, Dirk
  • Kazeem, Gbenga
  • Desaiah, Durisala
  • Leschinger, Monika I.
  • von Pawel, Joachim1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
Type
Published Article
Journal
European Journal of Cancer
Publisher
Elsevier
Publication Date
2014
Identifiers
DOI: 10.1016/j.ejca.2014.03.007
Source
Elsevier
Keywords
License
Unknown
Report this publication

Statistics

Seen <100 times